glp 1 cv benefit Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon‐like peptide‐1 receptor agonists. European Journal of Heart Failure expert consensus document - Monzo - 2025 of benefits elucidated in diabetes

There are several higher-risk situations, including dose escalation, constipation, nausea, vomiting, stomach pain, breathing trouble, higher-than-typical doses, and other conditions that slow stomach emptying

If you need significant support adjusting your dose or managing side effects, you may need to initiate those conversations yourself

Some patients may be missing out on treatment because they simply don't know they have coverage

GLP-1 medications are prescription drugs, and any changes to your treatment plan should be discussed with your healthcare provider

Because patients may receive GLP-1 prescriptions from primary care, endocrinology, or obesity medicine specialists, coordination with obstetrics and gynecology is essential

10.1038/s41573-020-00135-8 92 NauckM